LILRB1,NETosisPseudomonas aeruginosa-

Shaochu Zheng1, Shihao Yang1, Yuting Huang1

  • 1Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People's Republic of China.

PubMed
概括

白血球免疫球蛋白样受体B1 (LILRB1) 在耐药性Pseudomonas aeruginosa支气管切开症患者中较低,抑制中性粒细胞活性. 在这些患者中,LILRB1可能是减少呼吸道炎症的治疗点.